As a mild bio-based raw material in pharmaceutical R&D, rhamnolipids have good biocompatibility and functions such as emulsification and solubilization, transdermal penetration enhancement and antibacterial activity. They are highly compatible with the weakly acidic to neutral physiological environment of human skin and mucous membranes, mild and low-irritating, and show good synergistic effects when compounded with mainstream active ingredients such as traditional Chinese medicine extracts, peptides and hyaluronic acid.

In topical and transdermal preparations, they can serve as solubilizing and penetration-enhancing excipients, improving the solubility and skin permeation efficiency of poorly soluble ingredients while reducing formulation irritation. Their antibacterial and anti-biofilm properties make them suitable for wound care, oral and periodontal care, medical cleaning and disinfection, and antibacterial coatings for medical devices.

The products are completely biodegradable with no risk of bioaccumulation in the body, in line with the development direction of the personal care and pharmaceutical industries toward natural, safe products and reduced use of chemical auxiliaries.

ARTEMIS relies on mature and stable fermentation and purification mass-production processes to ensure batch-to-batch consistency of high-purity refined rhamnolipids. We are committed to meeting the industry’s demand for high purity. While optimizing formulation costs and reducing excipient irritation, we enhance the antibacterial efficacy of medical ingredients. They are the preferred bio-based raw material for natural medical excipients, medical cleaning consumables and natural emulsifying ingredients for medical applications.